Cite

HARVARD Citation

    Usiskin, K. et al. (2014). Safety and Tolerability of Canagliflozin in Patients With Type 2 Diabetes Mellitus: Pooled Analysis of Phase 3 Study Results. Postgraduate medicine. 126 (3), pp. 16-34. [Online]. 
  
Back to record